Methodology

All entries for: Kalevala Therapeutics Inc.

July 11, 2026

Kalevala Therapeutics Inc.

Orphan Drug Designation

treatment of Unverricht Lundborg disease

Disease Area: Rare Diseases
Source
June 8, 2026

Kalevala Therapeutics Inc.

Orphan Drug Designation

treatment of alternating hemiplegia

Disease Area: Rare Diseases
Source
Scroll to Top